Stock listing
ALDX Stock Price, News, Filings & Events — Aldeyra Therapeutics, Inc.
Selected listing: ALDX · NASDAQ · USD · US
This page tracks Aldeyra Therapeutics, Inc.'s ALDX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALDX:NASDAQ. ALDX:NASDAQ is the stock-level entry point for investors researching Aldeyra Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aldeyra Therapeutics, Inc. is a public company traded under the ticker ALDX in the American market. The company has a market capitalization of approximately $101.94 million. Aldeyra focuses on developing innovative therapies for immune-mediated diseases and other conditions.
- Ticker
- ALDX:NASDAQ
- Asset type
- Stock
- Market cap
- $72.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Aldeyra Therapeutics, Inc. ALDX:NASDAQ stock context
This page tracks Aldeyra Therapeutics, Inc.'s ALDX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALDX:NASDAQ. ALDX:NASDAQ is the stock-level entry point for investors researching Aldeyra Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aldeyra Therapeutics, Inc. is a public company traded under the ticker ALDX in the American market. The company has a market capitalization of approximately $101.94 million. Aldeyra focuses on developing innovative therapies for immune-mediated diseases and other conditions.
Latest news from Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics to Host Regulatory Update Webcast
September 28, 2026
Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors
June 9, 2026
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
June 2, 2026
Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease
December 15, 2025
Aldeyra Therapeutics, Inc. earnings calls
Aldeyra Therapeutics, Inc. (ALDX) Q2 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q4 2022 Earnings Call
March 9, 2023 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q3 2022 Earnings Call
November 10, 2022 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q2 2022 Earnings Call
August 5, 2022 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q1 2022 Earnings Call
May 5, 2022 · Replay with transcript and chapters
Aldeyra Therapeutics, Inc. (ALDX) Q4 2021 Earnings Call
March 17, 2022 · Replay with transcript and chapters
Research Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for ALDX:NASDAQ.
Aldeyra Therapeutics, Inc. company profile
View the public company page for Aldeyra Therapeutics, Inc. on 6ix.
Aldeyra Therapeutics, Inc. news
Read company news and market updates connected to Aldeyra Therapeutics, Inc..
Aldeyra Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Aldeyra Therapeutics, Inc..
Alternate listings
ALDX:BOATS
US · USD
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is ALDX:NASDAQ.
A111X8:LSX
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is ALDX:NASDAQ.
137:GETTEX
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is ALDX:NASDAQ.
A111X8:LS
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is ALDX:NASDAQ.
137:FWB
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is ALDX:NASDAQ.
137:TRADEGATE
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is ALDX:NASDAQ.
137:DUS
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is ALDX:NASDAQ.
137:MUN
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is ALDX:NASDAQ.
137:SWB
DE · EUR
Alternate listing for Aldeyra Therapeutics, Inc.; the primary context on this page is ALDX:NASDAQ.